Cue Health Stock

Cue Health Equity

The The Equity of Cue Health (HLTHQ) as of Aug 7, 2026 is 250.25 M USD. In the previous year, The Equity was 576.50 M USD — a change of -56.59% (lower).

Equity

250.25 MUSD

YoY

-56.59%

Last updated:

In 2026, Cue Health's equity was 250.25 M USD, a -56.59% increase from the 576.50 M USD equity in the previous year.

Access this data via the Eulerpool API

Cue Health Stock analysis

What does Cue Health do? Cue Health Inc. is a San Diego-based company specialized in the development and distribution of smart, mobile diagnostic devices. The company was founded in 2010 by Ayub Khattak and Dan Sullivan and has since expanded into various sectors. Cue Health's main business is the development of diagnostic devices that allow end-users to quickly and easily perform diagnostic tests. With a handheld device and proprietary software, customers can perform a wide range of tests in many areas, including tests for flu, colds, inflammatory diseases, sexually transmitted diseases, and COVID-19. Cue Health's business model is based on the idea of providing user-friendliness and portability in the field of diagnostics. With the technology, patients can independently perform diagnostic tests without having to visit a doctor. This not only saves time but also reduces costs for the customer. Since its founding, Cue Health has expanded into several sectors. In addition to the handheld diagnostic device, the company also offers solutions for the healthcare services sector. Through partnerships with biotech companies and medical institutions, the company assists in the development and marketing of diagnostic tests. An important part of Cue Health's history is the development of COVID-19 tests. The company quickly responded to develop a solution for COVID-19 tests that are both safe and easier to use. The Cue COVID-19 Test Kit complies with the requirements of the US Food and Drug Administration and is used in the USA. The test only requires a simple nasal swab, which is then inserted into the handheld device. Within minutes, the user receives the test result. Cue Health intends to continue expanding its technology to offer users a wider range of diagnostic test solutions. The previous tests have shown that the company is capable of delivering innovative solutions to the diagnostics market. The ability to receive fast, accurate, and affordable diagnostic solutions is invaluable for many people, especially those in hard-to-reach locations and without direct access to medical professionals. Overall, Cue Health is a highly innovative company specializing in excellent diagnostic technology and products for the healthcare industry. The products and services of Cue Health have the potential to revolutionize healthcare for all by making diagnostic tests safer, faster, and more convenient. Cue Health is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Cue Health's Equity

Cue Health's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cue Health's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Cue Health's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Cue Health's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Cue Health’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Cue Health stock

The Equity of Cue Health is 250.25 M USD in 2026.

The Equity of Cue Health changed from 576.50 M USD to 250.25 M USD, representing a -56.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Cue Health since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Cue Health historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Cue Health

All Key Metrics — Cue Health